Gut microbes may determine how patients respond to a drug that delays the onset of type 1 diabetes
Teplizumab delays type 1 diabetes (T1D) in at-risk people in the TN10 trial, but participants respond differently to the treatment. ...
Teplizumab delays type 1 diabetes (T1D) in at-risk people in the TN10 trial, but participants respond differently to the treatment. ...
Credit: Pixabay/CC0 Public domain In research published in Nature Structural and molecular biologyResearchers at the University of Birmingham have discovered ...
© 2023 Manhattan Tribune -By Millennium Press
© 2023 Manhattan Tribune -By Millennium Press